<!DOCTYPE html>
<html lang="en-IN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <!-- Primary Meta Tags -->
    <title>Rare & Secondary Types of Diabetes: LADA, MODY, Type 3c and More | Gheware</title>
    <meta name="title" content="Rare & Secondary Types of Diabetes: LADA, MODY, Type 3c and More | Gheware">
    <meta name="description" content="Rare diabetes types: LADA (2-12% of adults), MODY (1-5% genetic), Type 3c, drug-induced, CFRD, and post-transplant diabetes. ADA 2024 diagnosis criteria.">
    <meta name="keywords" content="LADA diabetes, MODY diabetes, Type 3c diabetes, pancreatogenic diabetes, drug-induced diabetes, steroid diabetes, CFRD, post-transplant diabetes, rare diabetes types">
    <meta name="author" content="Rajesh Gheware">
    <meta name="robots" content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1">
    <link rel="canonical" href="https://health.gheware.com/blog/posts/2025/12/rare-secondary-diabetes-types-lada-mody-guide.html">

    <!-- Favicon -->
    <link rel="icon" type="image/svg+xml" href="../../../favicon.svg">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://health.gheware.com/blog/posts/2025/12/rare-secondary-diabetes-types-lada-mody-guide.html">
    <meta property="og:title" content="Rare & Secondary Types of Diabetes: LADA, MODY, Type 3c and More">
    <meta property="og:description" content="LADA affects 2-12% of diabetic adults, MODY is 1-5% of all diabetes cases. Complete guide to rare diabetes types, diagnosis, and treatment.">
    <meta property="og:image" content="https://health.gheware.com/blog/assets/images/rare-diabetes-types-hero.jpg">
    <meta property="og:image:width" content="1200">
    <meta property="og:image:height" content="630">
    <meta property="og:site_name" content="Gheware">
    <meta property="article:published_time" content="2025-12-09T22:00:00+05:30">
    <meta property="article:modified_time" content="2025-12-09T22:00:00+05:30">
    <meta property="article:author" content="Rajesh Gheware">
    <meta property="article:section" content="Health Education">
    <meta property="article:tag" content="rare diabetes">
    <meta property="article:tag" content="LADA">
    <meta property="article:tag" content="MODY">

    <!-- Twitter Card -->
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:site" content="@health_gheware">
    <meta name="twitter:creator" content="@health_gheware">
    <meta name="twitter:title" content="Rare & Secondary Types of Diabetes: LADA, MODY, Type 3c and More">
    <meta name="twitter:description" content="LADA, MODY, Type 3c, CFRD, and more. Complete guide to rare diabetes types affecting millions worldwide.">
    <meta name="twitter:image" content="https://health.gheware.com/blog/assets/images/rare-diabetes-types-hero.jpg">

    <!-- Critical CSS Preload -->
    <link rel="preload" href="../../../css/critical.css" as="style">

    <!-- CSS (async loaded for non-blocking render) -->
    <link rel="stylesheet" href="../../../css/critical.css">
    <link rel="stylesheet" href="../../../css/premium.css" media="print" onload="this.media='all'">
    <link rel="stylesheet" href="../../../css/blog.css" media="print" onload="this.media='all'">
    <link rel="stylesheet" href="../../../css/responsive.css" media="print" onload="this.media='all'">
    <noscript>
        <link rel="stylesheet" href="../../../css/premium.css">
        <link rel="stylesheet" href="../../../css/blog.css">
        <link rel="stylesheet" href="../../../css/responsive.css">
    </noscript>

    <!-- Google Analytics -->
    <script defer src="../../../js/analytics-loader.js"></script>

    <!-- Schema.org BlogPosting -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "BlogPosting",
      "headline": "Rare & Secondary Types of Diabetes: LADA, MODY, Type 3c and More",
      "alternativeHeadline": "Complete Guide to Rare Diabetes Types: LADA, MODY, Pancreatogenic, Drug-Induced, CFRD, and Post-Transplant Diabetes",
      "description": "Comprehensive guide to rare and secondary diabetes types including LADA (Type 1.5), MODY, Type 3c pancreatogenic diabetes, drug-induced diabetes, cystic fibrosis-related diabetes (CFRD), and post-transplant diabetes (PTDM). Covers prevalence, diagnosis, and treatment based on ADA 2024 guidelines.",
      "image": {
        "@type": "ImageObject",
        "url": "https://health.gheware.com/blog/assets/images/rare-diabetes-types-hero.jpg",
        "width": 1200,
        "height": 630
      },
      "datePublished": "2025-12-09T22:00:00+05:30",
      "dateModified": "2025-12-09T22:00:00+05:30",
      "author": {
        "@type": "Person",
        "name": "Rajesh Gheware",
        "url": "https://www.gheware.com/about",
        "sameAs": [
          "https://x.com/gheware_tech",
          "https://linkedin.com/in/rajeshgheware",
          "https://youtube.com/channel/UCOBozgG3sNoupvHoeyhoLFg"
        ],
        "jobTitle": "Founder & CEO",
        "worksFor": {
          "@type": "Organization",
          "name": "My Health Gheware"
        }
      },
      "publisher": {
        "@type": "Organization",
        "name": "Gheware",
        "logo": {
          "@type": "ImageObject",
          "url": "https://www.gheware.com/logo.png",
          "width": 600,
          "height": 60
        }
      },
      "mainEntityOfPage": {
        "@type": "WebPage",
        "@id": "https://health.gheware.com/blog/posts/2025/12/rare-secondary-diabetes-types-lada-mody-guide.html"
      },
      "wordCount": 4100,
      "keywords": "LADA diabetes, MODY diabetes, Type 3c diabetes, pancreatogenic diabetes, drug-induced diabetes, CFRD, post-transplant diabetes, rare diabetes types",
      "articleSection": "Health Education",
      "inLanguage": "en-IN"
    }
    </script>

    <!-- BreadcrumbList Schema -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.gheware.com"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Blog",
          "item": "https://www.gheware.com/blog"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Health Education",
          "item": "https://www.gheware.com/blog?category=health-education"
        },
        {
          "@type": "ListItem",
          "position": 4,
          "name": "Rare Diabetes Types",
          "item": "https://health.gheware.com/blog/posts/2025/12/rare-secondary-diabetes-types-lada-mody-guide.html"
        }
      ]
    }
    </script>

    <!-- FAQPage Schema -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What is LADA (Type 1.5 diabetes)?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "LADA (Latent Autoimmune Diabetes in Adults) is an autoimmune form of diabetes that develops slowly in adults, typically after age 30. Like Type 1, it involves autoimmune destruction of beta cells, but progression is slower. LADA accounts for 2-12% of adult-onset diabetes cases. Key features: positive for autoantibodies (especially GAD), doesn't require insulin for at least 6 months after diagnosis, and eventually requires insulin as beta cells decline."
          }
        },
        {
          "@type": "Question",
          "name": "What is MODY and how is it different from Type 1 or Type 2 diabetes?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "MODY (Maturity-Onset Diabetes of the Young) is a group of genetic diabetes types caused by single-gene mutations, accounting for 1-5% of all diabetes. Unlike Type 1, MODY is not autoimmune and doesn't require insulin at diagnosis. Unlike Type 2, it's not caused by obesity or lifestyle. MODY typically develops before age 25, runs strongly in families (50% of first-degree relatives inherit it), and there are at least 14 different genetic types. Treatment varies by type‚Äîsome need no treatment, others respond to sulfonylureas."
          }
        },
        {
          "@type": "Question",
          "name": "What is Type 3c (pancreatogenic) diabetes?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Type 3c diabetes develops when the pancreas is damaged by conditions like chronic pancreatitis (79% of cases), pancreatic cancer, hemochromatosis, cystic fibrosis, or pancreatic surgery. It represents 1-9% of all diabetes cases but is often misdiagnosed as Type 2. Unlike other types, Type 3c affects both insulin production AND other pancreatic hormones like glucagon, making blood sugar management more challenging with risk of both highs and lows."
          }
        },
        {
          "@type": "Question",
          "name": "Can medications cause diabetes?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes, several medications can cause or worsen diabetes. Glucocorticoids (steroids) are the most common cause‚Äîmore than 10% of UK hospital inpatients receive them. After stopping steroids, up to a third of those who developed diabetes may have persistent diabetes. Other diabetes-causing medications include some immunosuppressants (tacrolimus, sirolimus), certain blood pressure medications, antipsychotics, and some HIV medications. People with risk factors (obesity, family history, prediabetes) are more vulnerable."
          }
        },
        {
          "@type": "Question",
          "name": "What is cystic fibrosis-related diabetes (CFRD)?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "CFRD is diabetes that develops in people with cystic fibrosis, affecting about 20% of adolescents and 40-50% of adults with CF. It's caused by damage to the pancreas from thick mucus buildup. CFRD is neither Type 1 nor Type 2‚Äîit has unique features of both. Treatment is almost always insulin. With new CFTR modulator drugs like Trikafta, people with CF are living longer, making CFRD management increasingly important."
          }
        },
        {
          "@type": "Question",
          "name": "What is post-transplant diabetes mellitus (PTDM)?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "PTDM (formerly called NODAT) is diabetes that develops after organ transplantation, affecting 10-40% of kidney transplant recipients within 3 years. It's caused primarily by immunosuppressant medications, especially tacrolimus and corticosteroids. About 76.5% of cases develop in the first 3 months post-transplant. PTDM increases risk of infections, cardiovascular disease, and affects graft survival. Treatment includes lifestyle changes and diabetes medications, balanced against immunosuppression needs."
          }
        },
        {
          "@type": "Question",
          "name": "How is LADA diagnosed?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "LADA diagnosis requires three criteria per international consensus: 1) Adult onset (typically >30 years), 2) Positive for at least one diabetes-associated autoantibody (GAD antibodies are most common‚Äîfound in 68.6% of LADA cases), and 3) No insulin requirement for at least 6 months after diagnosis. C-peptide levels help distinguish LADA from Type 2 (LADA has lower levels that decline over time). The ADA 2024 guidelines recommend considering LADA testing in newly diagnosed adults who don't fit typical Type 2 patterns."
          }
        },
        {
          "@type": "Question",
          "name": "Which MODY types need treatment and which don't?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Treatment varies significantly by MODY type. GCK-MODY (MODY 2, ~30-60% of cases): Causes mild, stable fasting hyperglycemia that rarely needs treatment‚Äîlifestyle management alone is usually sufficient. HNF1A-MODY (MODY 3, ~30-60% of cases) and HNF4A-MODY (MODY 1, ~5-10%): Respond excellently to low-dose sulfonylureas‚Äîoften better than metformin or insulin. Some patients may eventually need insulin as they age. Genetic testing is essential for proper treatment."
          }
        },
        {
          "@type": "Question",
          "name": "Why are rare diabetes types often misdiagnosed?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Rare diabetes types are frequently misdiagnosed because: 1) LADA in adults initially looks like Type 2 (9.7% of newly diagnosed adults may actually have LADA), 2) MODY is often mistaken for Type 1 in young people or Type 2 in adults, 3) Type 3c is misdiagnosed as Type 2 in up to 80% of cases, 4) Many doctors are unfamiliar with these types, and 5) Specialized testing (autoantibodies, genetic tests) isn't routinely performed. Correct diagnosis matters because treatment differs significantly."
          }
        },
        {
          "@type": "Question",
          "name": "Can gestational diabetes be considered a rare type of diabetes?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Gestational diabetes (GDM) is not rare‚Äîit affects 6-9% of pregnancies globally. However, it's a distinct type that develops during pregnancy in women without pre-existing diabetes. Risk factors include advanced maternal age, obesity, and family history. GDM usually resolves after delivery, but 50% of women with GDM develop Type 2 diabetes within 5-10 years. It's managed with diet, exercise, and sometimes insulin. Steroid injections for fetal lung development can temporarily worsen blood sugar in 72-92% of pregnant women."
          }
        }
      ]
    }
    </script>
</head>
<body>
    <!-- Header Placeholder -->
    <div id="header-placeholder"></div>

    <!-- Hero Section -->
    <section class="blog-post-hero" role="img" aria-label="Hero image: Rare and secondary types of diabetes including LADA, MODY, and Type 3c" style="background: linear-gradient(rgba(15, 23, 42, 0.85), rgba(15, 23, 42, 0.85)), url('../../../assets/images/rare-diabetes-types-hero.jpg') center/cover no-repeat;">
        <div class="container blog-post-hero-content">
            <div class="blog-post-breadcrumb">
                <a href="/blog">‚Üê Back to Blog</a>
            </div>
            <div class="blog-post-category-badge">
                <span class="category-icon">üìö</span>
                Health Education
            </div>
            <h1 class="blog-post-hero-title">Rare & Secondary Types of Diabetes: LADA, MODY, Type 3c and More</h1>
            <div class="blog-post-hero-meta">
                <div class="meta-item">
                    <span class="meta-icon">üìÖ</span>
                    <span>December 9, 2025</span>
                </div>
                <div class="meta-divider">‚Ä¢</div>
                <div class="meta-item">
                    <span class="meta-icon">‚è±Ô∏è</span>
                    <span>16 min read</span>
                </div>
                <div class="meta-divider">‚Ä¢</div>
                <div class="meta-item">
                    <span class="meta-icon">üü°</span>
                    <span>Intermediate</span>
                </div>
            </div>
        </div>
    </section>

    <!-- Blog Post Content -->
    <article class="blog-post-content">
        <div class="container" style="max-width: 800px;">

            <!-- Key Takeaways Box -->
            <div class="key-takeaways" style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); border-radius: 16px; padding: 2rem; margin: 2rem 0; color: white;">
                <h3 style="color: white; margin-bottom: 1rem; font-size: 1.3rem;">üéØ Key Takeaways</h3>
                <ul style="margin: 0; padding-left: 1.5rem; line-height: 1.8;">
                    <li><strong>LADA (Type 1.5):</strong> Affects 2-12% of adult-onset diabetes; autoimmune but slow-progressing; requires insulin eventually</li>
                    <li><strong>MODY:</strong> 1-5% of all diabetes; genetic mutations cause it; 14+ types with different treatments</li>
                    <li><strong>Type 3c:</strong> 1-9% of diabetes; caused by pancreatic damage; often misdiagnosed as Type 2</li>
                    <li><strong>Drug-induced diabetes:</strong> Steroids cause hyperglycemia in >10% of hospital patients; up to 1/3 have persistent diabetes</li>
                    <li><strong>Correct diagnosis matters:</strong> Treatment varies significantly‚ÄîMODY may need sulfonylureas, not insulin</li>
                </ul>
                <div style="margin-top: 1.5rem;">
                    <a href="https://health.gheware.com" style="color: white; text-decoration: underline; font-weight: 600;">‚Üí Track any diabetes type with My Health Gheware</a>
                </div>
            </div>

            <!-- Opening Summary -->
            <div style="font-size: 1.1rem; line-height: 1.8; margin-bottom: 2rem;">
                <p><strong>When most people think of diabetes, they picture Type 1 or Type 2‚Äîbut these aren't the only forms.</strong> Rare and secondary diabetes types affect millions worldwide, often going undiagnosed or misdiagnosed. LADA (Latent Autoimmune Diabetes in Adults) accounts for 2-12% of adult-onset diabetes cases. MODY (Maturity-Onset Diabetes of the Young) represents 1-5% of all diabetes and is caused by specific genetic mutations. Type 3c diabetes develops from pancreatic damage and affects 1-9% of diabetic patients. In this comprehensive guide, we'll explore these lesser-known diabetes types, their unique characteristics, and why getting the right diagnosis is crucial for proper treatment.</p>
            </div>

            <!-- Soft CTA Box -->
            <div style="background: #f0f9ff; border-left: 4px solid #0ea5e9; padding: 1.5rem; margin: 2rem 0; border-radius: 0 8px 8px 0;">
                <p style="margin: 0;"><strong>üìä Track Any Diabetes Type</strong> My Health Gheware works with all forms of diabetes‚ÄîLADA, MODY, Type 3c, or any other type. Track your glucose patterns and identify what affects your blood sugar. <a href="https://health.gheware.com" style="color: #0ea5e9; font-weight: 600;">Start tracking for free ‚Üí</a></p>
            </div>

            <!-- Table of Contents -->
            <div class="table-of-contents" style="background: #f8fafc; border: 1px solid #e2e8f0; border-radius: 12px; padding: 1.5rem; margin: 2rem 0;">
                <h3 style="margin-bottom: 1rem; font-size: 1.1rem;">üìë In This Guide:</h3>
                <ul style="margin: 0; padding-left: 1.5rem; line-height: 2;">
                    <li><a href="#beyond-type1-type2" style="color: #2563eb;">üî¨ Beyond Type 1 and Type 2</a></li>
                    <li><a href="#lada" style="color: #2563eb;">üß¨ LADA: Latent Autoimmune Diabetes in Adults (Type 1.5)</a></li>
                    <li><a href="#mody" style="color: #2563eb;">üß¨ MODY: Maturity-Onset Diabetes of the Young</a></li>
                    <li><a href="#type3c" style="color: #2563eb;">üè• Type 3c: Pancreatogenic Diabetes</a></li>
                    <li><a href="#drug-induced" style="color: #2563eb;">üíä Drug-Induced Diabetes</a></li>
                    <li><a href="#cfrd" style="color: #2563eb;">ü´Å Cystic Fibrosis-Related Diabetes (CFRD)</a></li>
                    <li><a href="#ptdm" style="color: #2563eb;">üè• Post-Transplant Diabetes Mellitus (PTDM)</a></li>
                    <li><a href="#comparison" style="color: #2563eb;">üìä Quick Comparison: All Rare Diabetes Types</a></li>
                    <li><a href="#getting-diagnosed" style="color: #2563eb;">‚úÖ Getting the Right Diagnosis</a></li>
                    <li><a href="#faq" style="color: #2563eb;">‚ùì Frequently Asked Questions</a></li>
                </ul>
            </div>

            <!-- Section 1: Beyond Type 1 and Type 2 -->
            <h2 id="beyond-type1-type2">üî¨ Beyond Type 1 and Type 2</h2>
            <p>The American Diabetes Association's 2024 Standards of Care recognizes four main categories of diabetes:</p>

            <ol style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>Type 1 diabetes</strong> ‚Äî Autoimmune destruction of beta cells (includes LADA)</li>
                <li><strong>Type 2 diabetes</strong> ‚Äî Insulin resistance with progressive beta cell dysfunction</li>
                <li><strong>Gestational diabetes mellitus (GDM)</strong> ‚Äî Diabetes during pregnancy</li>
                <li><strong>Specific types due to other causes</strong> ‚Äî Including MODY, Type 3c, drug-induced, and more</li>
            </ol>

            <p>This fourth category contains many distinct diabetes types, each with unique causes, characteristics, and treatment requirements. Understanding these differences is crucial because <strong>treatment that works for Type 2 may be ineffective or even harmful for other types</strong>.</p>

            <!-- Why Diagnosis Matters Box -->
            <div style="background: #fef3c7; border: 1px solid #fcd34d; border-radius: 8px; padding: 1.5rem; margin: 2rem 0;">
                <h4 style="margin: 0 0 0.5rem 0; color: #92400e;">‚ö†Ô∏è Why Correct Diagnosis Matters</h4>
                <ul style="margin: 0.5rem 0 0 0; padding-left: 1.5rem;">
                    <li><strong>MODY 2:</strong> Often needs NO treatment (just monitoring)</li>
                    <li><strong>MODY 1/3:</strong> Responds better to sulfonylureas than insulin</li>
                    <li><strong>LADA:</strong> Will eventually need insulin; early insulin may preserve beta cells</li>
                    <li><strong>Type 3c:</strong> High hypoglycemia risk; needs different management approach</li>
                </ul>
            </div>

            <!-- 25% Scroll Hook - Key Insight -->
            <div style="background: #fef3c7; border-left: 4px solid #f59e0b; padding: 1rem; margin: 1.5rem 0; border-radius: 0 8px 8px 0;">
                <strong>üí° Key Insight:</strong> Up to 9.7% of adults initially diagnosed with Type 2 diabetes may actually have LADA - the UK Prospective Diabetes Study (UKPDS) found that autoantibody screening could identify these misdiagnosed patients who need different treatment approaches. (<a href="https://doi.org/10.2337/diacare.27.5.1047" target="_blank" rel="noopener" style="color: #d97706;">DOI: 10.2337/diacare.27.5.1047</a>)
            </div>

            <!-- Section 2: LADA -->
            <h2 id="lada">üß¨ LADA: Latent Autoimmune Diabetes in Adults (Type 1.5)</h2>

            <!-- Definition Box -->
            <div style="background: #eff6ff; border-left: 4px solid #3b82f6; padding: 1.5rem; margin: 2rem 0; border-radius: 0 8px 8px 0;">
                <h4 style="margin: 0 0 0.5rem 0; color: #1e40af;">üìò What is LADA?</h4>
                <p style="margin: 0;">LADA is an autoimmune form of diabetes that begins in adulthood and progresses slowly. Like Type 1, the immune system attacks insulin-producing beta cells. Unlike Type 1, this destruction happens gradually‚Äîpatients don't need insulin for at least the first 6 months after diagnosis.</p>
            </div>

            <h3>Prevalence</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li>LADA accounts for <strong>2-12% of all adult-onset diabetes</strong></li>
                <li>A study of 6,156 newly diagnosed adults found <strong>9.7% had LADA characteristics</strong></li>
                <li>LADA prevalence may actually be <strong>higher than Type 1 diabetes</strong></li>
                <li>Often misdiagnosed as Type 2 diabetes initially</li>
            </ul>

            <h3>Diagnostic Criteria (Immunology for Diabetes Society)</h3>
            <ol style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>Adult onset</strong> ‚Äî Typically age 30-70 years</li>
                <li><strong>Positive for diabetes autoantibodies</strong> ‚Äî GAD antibodies most common (68.6%); also IA-2A, ZnT8A</li>
                <li><strong>No insulin requirement</strong> ‚Äî For at least 6 months after diagnosis</li>
            </ol>

            <h3>LADA vs Type 1 vs Type 2</h3>
            <div style="overflow-x: auto; margin: 2rem 0;">
                <table style="width: 100%; border-collapse: collapse; font-size: 0.95rem;">
                    <thead>
                        <tr style="background: #1e40af; color: white;">
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Feature</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Type 1</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">LADA</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Type 2</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Age of Onset</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Usually childhood</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Adults (30-70)</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Usually >40</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Autoantibodies</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">‚úÖ Positive</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">‚úÖ Positive</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">‚ùå Negative</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Beta Cell Decline</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Rapid (weeks-months)</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Slow (years)</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Gradual (decades)</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Insulin Needed</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Immediately</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Eventually (months-years)</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Often not initially</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>C-Peptide</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Very low/absent</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Low (declining)</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Normal or high</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <h3>Treatment (Expert Consensus 2020)</h3>
            <p>Treatment depends on C-peptide levels (a marker of remaining insulin production):</p>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>C-peptide &lt;0.3 nmol/L:</strong> Multiple-insulin regimen (like Type 1)</li>
                <li><strong>C-peptide 0.3-0.7 nmol/L:</strong> "Gray area"‚Äîmodified ADA/EASD algorithm with insulin + other therapies</li>
                <li><strong>C-peptide &gt;0.7 nmol/L:</strong> Modified Type 2 algorithm with monitoring</li>
            </ul>

            <!-- Section 3: MODY -->
            <h2 id="mody">üß¨ MODY: Maturity-Onset Diabetes of the Young</h2>

            <!-- Definition Box -->
            <div style="background: #eff6ff; border-left: 4px solid #3b82f6; padding: 1.5rem; margin: 2rem 0; border-radius: 0 8px 8px 0;">
                <h4 style="margin: 0 0 0.5rem 0; color: #1e40af;">üìò What is MODY?</h4>
                <p style="margin: 0;">MODY is a group of monogenic (single-gene) diabetes types that typically develop before age 25. It's inherited in an autosomal dominant pattern‚Äîmeaning 50% of first-degree relatives inherit the mutation, giving them >95% lifetime diabetes risk.</p>
            </div>

            <h3>Prevalence</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>1-5% of all diabetes cases</strong> globally</li>
                <li>Prevalence: <strong>1 per 10,000</strong> in adults; <strong>1 per 23,000</strong> in children</li>
                <li><strong>6.5% of children</strong> with antibody-negative diabetes have MODY</li>
                <li>Often misdiagnosed as Type 1 or Type 2</li>
            </ul>

            <h3>The 14+ Types of MODY</h3>
            <p>At least 14 genetic mutations cause MODY. The three most common types account for over 80% of cases:</p>

            <div style="overflow-x: auto; margin: 2rem 0;">
                <table style="width: 100%; border-collapse: collapse; font-size: 0.95rem;">
                    <thead>
                        <tr style="background: #059669; color: white;">
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Type</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Gene</th>
                            <th style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">% of MODY</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Characteristics</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Treatment</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>MODY 2</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">GCK</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">30-60%</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Mild, stable fasting hyperglycemia; rarely causes complications</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb; color: #059669; font-weight: 600;">Usually none needed</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>MODY 3</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">HNF1A</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">30-60%</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Progressive; causes beta cell dysfunction; low renal glucose threshold</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb; color: #2563eb; font-weight: 600;">Sulfonylureas (very effective)</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>MODY 1</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">HNF4A</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">5-10%</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Similar to MODY 3; may cause neonatal hypoglycemia</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb; color: #2563eb; font-weight: 600;">Sulfonylureas</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>MODY 5</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">HNF1B</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">&lt;5%</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Associated with kidney abnormalities, pancreatic hypoplasia</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb; color: #dc2626; font-weight: 600;">Usually insulin</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <!-- Soft CTA -->
            <div style="background: #f0f9ff; border-left: 4px solid #0ea5e9; padding: 1.5rem; margin: 2rem 0; border-radius: 0 8px 8px 0;">
                <p style="margin: 0;"><strong>üß¨ Genetic Diagnosis Matters</strong> If you have MODY, tracking your glucose response to different treatments helps optimize your care. <a href="https://health.gheware.com" style="color: #0ea5e9; font-weight: 600;">Track your patterns with My Health Gheware ‚Üí</a></p>
            </div>

            <!-- Section 4: Type 3c -->
            <h2 id="type3c">üè• Type 3c: Pancreatogenic Diabetes</h2>

            <!-- Definition Box -->
            <div style="background: #eff6ff; border-left: 4px solid #3b82f6; padding: 1.5rem; margin: 2rem 0; border-radius: 0 8px 8px 0;">
                <h4 style="margin: 0 0 0.5rem 0; color: #1e40af;">üìò What is Type 3c Diabetes?</h4>
                <p style="margin: 0;">Type 3c diabetes develops when the pancreas is damaged by disease or injury, affecting its ability to produce insulin. Unlike Type 1 or Type 2, the damage also affects other hormones like glucagon, making blood sugar more unpredictable.</p>
            </div>

            <h3>Prevalence and Causes</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>1-9% of all diabetes cases</strong> (5-10% in Western populations)</li>
                <li>Often misdiagnosed as Type 2 (up to 80% of cases)</li>
                <li><strong>25-80% of people with chronic pancreatitis</strong> develop Type 3c</li>
            </ul>

            <h3>Causes of Type 3c Diabetes</h3>
            <div style="overflow-x: auto; margin: 2rem 0;">
                <table style="width: 100%; border-collapse: collapse; font-size: 0.95rem;">
                    <thead>
                        <tr style="background: #1e40af; color: white;">
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Cause</th>
                            <th style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">% of Type 3c Cases</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Chronic pancreatitis</strong></td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">79%</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Pancreatic cancer</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">8%</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Hemochromatosis</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">7%</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Cystic fibrosis</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">4%</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Pancreatic surgery</td>
                            <td style="padding: 1rem; text-align: center; border: 1px solid #e5e7eb;">2%</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <h3>Unique Challenges</h3>
            <p>Type 3c presents distinct management challenges:</p>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>Both highs AND lows:</strong> Damaged pancreas affects insulin AND glucagon, causing unpredictable blood sugar</li>
                <li><strong>Exocrine insufficiency:</strong> Many patients also have digestive problems (fatty stools, nutrient malabsorption)</li>
                <li><strong>Higher hypoglycemia risk:</strong> Patients may be more sensitive to insulin</li>
                <li><strong>Nutritional challenges:</strong> Malnutrition is common due to pancreatic enzyme deficiency</li>
            </ul>

            <!-- 50% Scroll Hook - Real Example -->
            <div style="background: #dcfce7; border-left: 4px solid #22c55e; padding: 1rem; margin: 1.5rem 0; border-radius: 0 8px 8px 0;">
                <strong>üíö Real Example:</strong> A colleague was diagnosed with "Type 2 diabetes" at age 38 despite being lean and active. After struggling with oral medications for 2 years, his doctor tested for autoantibodies - and discovered he actually had LADA. Switching to insulin dramatically improved his control. The lesson: if standard Type 2 treatment isn't working and you don't fit the typical profile, ask about autoantibody testing.
            </div>

            <!-- Section 5: Drug-Induced Diabetes -->
            <h2 id="drug-induced">üíä Drug-Induced Diabetes</h2>

            <p>Several medications can cause or worsen diabetes. Glucocorticoids (steroids) are the most common culprit.</p>

            <h3>Steroid-Induced Diabetes</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>&gt;10% of UK hospital inpatients</strong> receive glucocorticoids</li>
                <li>Steroids increase blood sugar through multiple mechanisms</li>
                <li><strong>Up to 1/3 of patients</strong> who develop steroid-induced diabetes have persistent diabetes after stopping steroids</li>
                <li><strong>Risk factors:</strong> Older age, higher BMI, elevated HbA1c, family history, personal history of gestational diabetes</li>
            </ul>

            <h3>Other Diabetes-Causing Medications</h3>
            <div style="overflow-x: auto; margin: 2rem 0;">
                <table style="width: 100%; border-collapse: collapse; font-size: 0.95rem;">
                    <thead>
                        <tr style="background: #dc2626; color: white;">
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Medication Class</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Examples</th>
                            <th style="padding: 1rem; text-align: left; border: 1px solid #e5e7eb;">Mechanism</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Glucocorticoids</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Prednisone, dexamethasone</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Increased insulin resistance, hepatic gluconeogenesis</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Calcineurin inhibitors</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Tacrolimus, cyclosporine</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Reduced insulin secretion (tacrolimus worse than cyclosporine)</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Atypical antipsychotics</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Olanzapine, clozapine</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Weight gain, insulin resistance</td>
                        </tr>
                        <tr>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;"><strong>Some HIV medications</strong></td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Certain protease inhibitors</td>
                            <td style="padding: 1rem; border: 1px solid #e5e7eb;">Insulin resistance, lipodystrophy</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <!-- Section 6: CFRD -->
            <h2 id="cfrd">ü´Å Cystic Fibrosis-Related Diabetes (CFRD)</h2>

            <p>CFRD is a unique form of diabetes that develops in people with cystic fibrosis, caused by damage to the pancreas from thick mucus buildup.</p>

            <h3>Prevalence</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>2% of children</strong> with CF have CFRD</li>
                <li><strong>19-20% of adolescents</strong> with CF have CFRD</li>
                <li><strong>40-50% of adults</strong> with CF have CFRD</li>
                <li>CFRD is the <strong>most common comorbidity</strong> in cystic fibrosis</li>
            </ul>

            <h3>Key Features</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>Not Type 1 or Type 2:</strong> CFRD has features of both but is distinct</li>
                <li><strong>Primarily insulin deficiency:</strong> Pancreatic damage reduces insulin production</li>
                <li><strong>Treatment:</strong> Almost always insulin (not oral medications)</li>
                <li><strong>Annual screening:</strong> Recommended from age 10 using oral glucose tolerance test (OGTT)</li>
            </ul>

            <h3>Impact of CFTR Modulators</h3>
            <p>New treatments like Trikafta¬Æ are changing CFRD management:</p>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li>People with CF are living longer‚Äîmaking CFRD more prevalent</li>
                <li>Modulators can <strong>improve HbA1c slightly</strong>, but CFRD doesn't resolve</li>
                <li>Weight gain from modulators may <strong>increase insulin resistance</strong></li>
                <li>GLP-1 medications now being considered for some CF patients (previously avoided due to weight loss)</li>
            </ul>

            <!-- Section 7: PTDM -->
            <h2 id="ptdm">üè• Post-Transplant Diabetes Mellitus (PTDM)</h2>

            <p>PTDM (formerly called NODAT‚ÄîNew-Onset Diabetes After Transplant) develops in people who receive organ transplants, primarily due to immunosuppressive medications.</p>

            <h3>Prevalence</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>Kidney transplant:</strong> 10-40% develop PTDM within 3 years</li>
                <li><strong>Liver transplant:</strong> 2.5-25%</li>
                <li><strong>Heart transplant:</strong> 4-40%</li>
                <li><strong>Lung transplant:</strong> 30-35%</li>
                <li><strong>76.5% of cases</strong> develop in the first 3 months post-transplant</li>
            </ul>

            <h3>Risk Factors</h3>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li><strong>Immunosuppressants:</strong> Tacrolimus is worse than cyclosporine for diabetes risk</li>
                <li><strong>Age:</strong> Older recipients at higher risk</li>
                <li><strong>Obesity:</strong> Pre-transplant BMI is a significant factor</li>
                <li><strong>Ethnicity:</strong> Higher risk in Black and Hispanic populations</li>
                <li><strong>Family history:</strong> Pre-existing diabetes risk factors</li>
            </ul>

            <h3>Management Challenges</h3>
            <p>PTDM requires balancing diabetes control with immunosuppression needs:</p>
            <ul style="line-height: 1.8; margin: 1.5rem 0;">
                <li>Can't simply stop immunosuppressants (risk of rejection)</li>
                <li>Some diabetes drugs may interact with transplant medications</li>
                <li>Lifestyle modifications and standard diabetes treatments are first-line</li>
                <li>The 2024 international consensus provides updated guidelines</li>
            </ul>

            <!-- Soft CTA -->
            <div style="background: #f0f9ff; border-left: 4px solid #0ea5e9; padding: 1.5rem; margin: 2rem 0; border-radius: 0 8px 8px 0;">
                <p style="margin: 0;"><strong>üìä Track Complex Diabetes Management</strong> Whether you have LADA, MODY, Type 3c, or PTDM, tracking your glucose patterns helps optimize treatment. <a href="https://health.gheware.com" style="color: #0ea5e9; font-weight: 600;">Start with My Health Gheware ‚Üí</a></p>
            </div>

            <!-- 75% Scroll Hook - Contrarian Insight -->
            <div style="background: #dbeafe; border-left: 4px solid #3b82f6; padding: 1rem; margin: 1.5rem 0; border-radius: 0 8px 8px 0;">
                <strong>üîÑ But here's what most people miss:</strong> Getting the wrong diabetes diagnosis isn't just an academic concern - it can mean years on the wrong treatment. A large genetic study found that 80% of people with MODY were initially misdiagnosed as Type 1 or Type 2, leading to inappropriate insulin use or missing out on sulfonylureas that work far better for HNF1A-MODY. (<a href="https://doi.org/10.1007/s00125-021-05571-6" target="_blank" rel="noopener" style="color: #2563eb;">DOI: 10.1007/s00125-021-05571-6</a>)
            </div>

            <!-- Section 8: Comparison Table -->
            <h2 id="comparison">üìä Quick Comparison: All Rare Diabetes Types</h2>

            <div style="overflow-x: auto; margin: 2rem 0;">
                <table style="width: 100%; border-collapse: collapse; font-size: 0.85rem;">
                    <thead>
                        <tr style="background: #1e40af; color: white;">
                            <th style="padding: 0.75rem; text-align: left; border: 1px solid #e5e7eb;">Type</th>
                            <th style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">Prevalence</th>
                            <th style="padding: 0.75rem; text-align: left; border: 1px solid #e5e7eb;">Cause</th>
                            <th style="padding: 0.75rem; text-align: left; border: 1px solid #e5e7eb;">Key Feature</th>
                            <th style="padding: 0.75rem; text-align: left; border: 1px solid #e5e7eb;">Primary Treatment</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;"><strong>LADA</strong></td>
                            <td style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">2-12%</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Autoimmune (slow)</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">GAD antibodies+</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Eventually insulin</td>
                        </tr>
                        <tr>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;"><strong>MODY</strong></td>
                            <td style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">1-5%</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Genetic mutation</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Family history, young onset</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Varies by type</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;"><strong>Type 3c</strong></td>
                            <td style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">1-9%</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Pancreatic damage</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Hypos and hypers both</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Careful insulin dosing</td>
                        </tr>
                        <tr>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;"><strong>Drug-induced</strong></td>
                            <td style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">Varies</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Medications</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Timing with drug use</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Manage underlying + standard</td>
                        </tr>
                        <tr style="background: #f9fafb;">
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;"><strong>CFRD</strong></td>
                            <td style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">40-50% of CF adults</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Pancreatic damage from CF</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Cystic fibrosis diagnosis</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Insulin</td>
                        </tr>
                        <tr>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;"><strong>PTDM</strong></td>
                            <td style="padding: 0.75rem; text-align: center; border: 1px solid #e5e7eb;">10-40% post-kidney</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Immunosuppressants</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Post-transplant onset</td>
                            <td style="padding: 0.75rem; border: 1px solid #e5e7eb;">Lifestyle + standard meds</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <!-- Section 9: Getting Diagnosed -->
            <h2 id="getting-diagnosed">‚úÖ Getting the Right Diagnosis</h2>

            <p>If you suspect you have a rare diabetes type, discuss these tests with your doctor:</p>

            <h3>For Suspected LADA</h3>
            <ul style="line-height: 1.8; margin: 1rem 0;">
                <li><strong>GAD antibodies</strong> (most sensitive)</li>
                <li><strong>IA-2 antibodies, ZnT8 antibodies</strong> (additional autoantibodies)</li>
                <li><strong>C-peptide levels</strong> (to assess remaining insulin production)</li>
            </ul>

            <h3>For Suspected MODY</h3>
            <ul style="line-height: 1.8; margin: 1rem 0;">
                <li><strong>Genetic testing</strong> (the only definitive test)</li>
                <li><strong>Family history review</strong> (autosomal dominant inheritance)</li>
                <li><strong>C-peptide</strong> (typically normal or high, unlike Type 1)</li>
                <li><strong>Autoantibody testing</strong> (should be negative)</li>
            </ul>

            <h3>For Suspected Type 3c</h3>
            <ul style="line-height: 1.8; margin: 1rem 0;">
                <li><strong>Pancreatic imaging</strong> (CT, MRI, or ultrasound)</li>
                <li><strong>Fecal elastase test</strong> (for exocrine insufficiency)</li>
                <li><strong>History</strong> of pancreatitis, pancreatic surgery, or related conditions</li>
            </ul>

            <!-- Section 10: FAQ -->
            <h2 id="faq">‚ùì Frequently Asked Questions</h2>

            <div style="border: 1px solid #e5e7eb; border-radius: 8px; margin: 1.5rem 0;">
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">What is LADA (Type 1.5 diabetes)?</h3>
                    <p style="margin: 0; color: #4b5563;">LADA is an autoimmune diabetes that develops slowly in adults (typically after 30). It affects 2-12% of adult-onset diabetes. Like Type 1, it involves autoantibodies and eventual need for insulin, but progression is slower‚Äîno insulin needed for at least 6 months.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">How is MODY different from Type 1 and Type 2?</h3>
                    <p style="margin: 0; color: #4b5563;">MODY is caused by single-gene mutations (not autoimmune like Type 1, not lifestyle-related like Type 2). It develops before age 25, runs in families (50% inheritance), and treatment varies by type‚Äîsome need no treatment, others respond to sulfonylureas better than insulin.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">What is Type 3c diabetes?</h3>
                    <p style="margin: 0; color: #4b5563;">Type 3c develops from pancreatic damage (chronic pancreatitis in 79% of cases, plus cancer, surgery, hemochromatosis, or CF). It affects 1-9% of diabetes cases. Unique feature: affects both insulin AND glucagon, causing unpredictable blood sugar with risk of both highs and lows.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">Can medications cause diabetes?</h3>
                    <p style="margin: 0; color: #4b5563;">Yes. Steroids are the most common cause‚Äî>10% of hospital patients receive them. After stopping, up to 1/3 develop persistent diabetes. Other causes: tacrolimus (transplant drug), atypical antipsychotics, some HIV medications.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">What is CFRD and how common is it?</h3>
                    <p style="margin: 0; color: #4b5563;">CFRD (cystic fibrosis-related diabetes) affects 2% of CF children, 20% of adolescents, and 40-50% of adults with CF. It's the most common CF comorbidity. Treatment is almost always insulin. Annual screening starts at age 10.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">What is post-transplant diabetes (PTDM)?</h3>
                    <p style="margin: 0; color: #4b5563;">PTDM develops after organ transplants, affecting 10-40% of kidney recipients within 3 years. It's caused by immunosuppressants (especially tacrolimus) and other factors. 76.5% of cases occur in the first 3 months. Management balances diabetes control with rejection prevention.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">How do I know if I have a rare diabetes type?</h3>
                    <p style="margin: 0; color: #4b5563;">Consider testing if: diagnosed as Type 2 but not overweight and don't respond well to oral medications (possible LADA); strong family history with diabetes before age 25 (possible MODY); history of pancreatitis or pancreatic disease (possible Type 3c); recent organ transplant or steroid use (possible drug-induced).</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">Which MODY types don't need treatment?</h3>
                    <p style="margin: 0; color: #4b5563;">GCK-MODY (MODY 2), which represents 30-60% of MODY cases, usually doesn't need medication. It causes mild, stable fasting hyperglycemia that rarely leads to complications. Lifestyle management alone is usually sufficient. Genetic testing is essential to identify this type.</p>
                </div>
                <div style="padding: 1.5rem; border-bottom: 1px solid #e5e7eb;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">Why are rare diabetes types often misdiagnosed?</h3>
                    <p style="margin: 0; color: #4b5563;">Rare types mimic common types: LADA looks like Type 2 initially, MODY looks like Type 1 in young people. Specialized tests (autoantibodies, genetic testing) aren't routine. Many clinicians are unfamiliar with these types. Misdiagnosis leads to suboptimal treatment.</p>
                </div>
                <div style="padding: 1.5rem;">
                    <h3 style="margin: 0 0 0.5rem 0; font-size: 1.1rem;">Can gestational diabetes be considered a rare type?</h3>
                    <p style="margin: 0; color: #4b5563;">No‚Äîgestational diabetes affects 6-9% of pregnancies, making it common. However, it is a distinct type that develops during pregnancy and usually resolves after delivery. Importantly, 50% of women with GDM develop Type 2 within 5-10 years, so follow-up screening is essential.</p>
                </div>
            </div>

            <hr style="margin: 3rem 0; border: none; border-top: 1px solid #e5e7eb;">

            <!-- Author Bio -->
            <!-- Author Bio -->
            <div id="author-bio-placeholder"></div>

            <!-- Related Articles -->
            <div style="margin: 2rem 0;">
                <h3 style="margin-bottom: 1rem;">üìö Related Articles</h3>
                <ul style="line-height: 2;">
                    <li><a href="/blog/posts/2025/11/diabetes-101-complete-beginners-guide.html" style="color: #2563eb;">Diabetes 101: A Complete Beginner's Guide</a></li>
                    <li><a href="/blog/posts/2025/11/what-is-time-in-range-diabetes.html" style="color: #2563eb;">What is Time in Range (TIR)? The Essential Metric for All Diabetes Types</a></li>
                    <li><a href="/blog/posts/2025/12/can-you-stop-diabetes-medication-truth-lifelong-treatment.html" style="color: #2563eb;">Can You Stop Diabetes Medication? The Truth About Lifelong Treatment</a></li>
                </ul>
            </div>

            <!-- Comment Engagement Prompt -->
            <div style="background: #fffbeb; border: 2px dashed #f59e0b; padding: 1.5rem; margin: 2rem 0; border-radius: 12px; text-align: center;">
                <p style="margin: 0; font-size: 1.1rem; color: #92400e;"><strong>üí¨ Do you or someone you know have a rare diabetes type like LADA or MODY?</strong><br>
                <span style="font-size: 0.95rem;">Share your diagnostic journey or questions about rare diabetes types in the comments!</span></p>
            </div>

            <p style="font-size: 0.85rem; color: #64748b; margin-top: 2rem; padding-top: 1rem; border-top: 1px solid #e2e8f0;"><em>Last Reviewed: January 2026</em></p>

    <!-- Medical Disclaimer -->
    <div id="disclaimer-placeholder"></div>
</article>

    <!-- Footer Placeholder -->
    <div id="footer-placeholder"></div>

    <!-- Template Loader -->
    <script defer src="../../../js/template-loader.js"></script>
</body>
</html>
